Table 2.
Neoplasms in which eosinophils are likely to be clonal cells |
Acute eosinophilic leukemia |
CEL |
Acute myeloid leukemia with inv(16) (FAB AML M4eo) |
Chronic myeloid leukemia |
Myeloid neoplasms with PDGFR abnormalities (WHO types) |
Hematopoietic neoplasms with FGFR1 abnormalities (WHO types) |
Smoldering systemic mastocytosis |
Aggressive systemic mastocytosis |
Mast cell leukemia |
Neoplasms in which eosinophils may or may not be part of the malignant clone |
Other MPN with eosinophilia* |
MDS with eosinophilia |
Other MDS/MPN overlap syndromes with eosinophilia* |
Indolent systemic mastocytosis |
Neoplasms in which eosinophils usually are not part of the malignant clone |
Hodgkin disease |
B-or T-cell non-Hodgkin lymphoma |
Acute lymphoblastic leukemia |
Chronic lymphocytic leukemia |
Langerhans cell histiocytosis |
*Other MPN or MPN/MDS: neoplasms where no abnormalities in the PDGFR or FGFR1 genes are detectable.
CEL, chronic eosinophilic leukemia; PDGFR, platelet-derived growth factor receptor; FGFR, fibroblast growth factor receptor; MPN, myeloproliferative neoplasm (s); MDS, myelodysplastic syndrome(s).
WHO, World Health Organization.